Quantcast

Johnson & Johnson Finalizes $2.2 Billion Personal Injury Settlement

Johnson & Johnson Agrees to Pay $2.2 Billion in Personal Injury Settlement, Various States Receive Settlement Money On Monday, November 4th, Johnson & Johnson agreed to pay $2.2 billion for a personal injury settlement involving off-label use of their antipsychotic, Risperdal. Now, various states are receiving settlement money. According to the original lawsuit, Johnson & Johnson and their subsidiary Janssen promoted Risperdal for off-label and unapproved uses between 1999 and 2005, such as controlling aggression in elderly … [Read more...]